Clinical trials
Genetic Predisposition to Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| The Affiliated Hospital of Xuzhou Medical University | 2 |
| Beijing Friendship Hospital | 1 |
| Children's Hospital of Fudan University | 1 |
| China Medical University, China | 1 |
| National Cancer Institute (NCI) | 1 |
| Shenzhen Center for Chronic Disease Control | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Xuanwu Hospital, Beijing | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Predisposition to Disease | 11 |
| Breast Neoplasms | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Alzheimer Disease | 1 |
| Chemical and Drug Induced Liver Injury | 1 |
| Colorectal Neoplasms | 1 |
| Congenital Abnormalities | 1 |
| Genetic Diseases, Inborn | 1 |
| Metabolic Diseases | 1 |
| Nasopharyngeal Carcinoma | 1 |
Trials
Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.